ADVB Key Statistics
High
17.50
Open
8.32
Volume
18.89M
Low
8.08
Prev. Close
7.08
Trading Value
242.22M
52-Week High
17.50
Relative Volume
4.932
Amplitude (%)
133.05%
52-Week Low
3.61
Turnover Rate
1143.54%
Market Cap
14.70M
P/E Ratio (TTM)
44.47
P/E Ratio (Annual)
--
P/B Ratio
1.27
P/S Ratio
--
Earnings Per Share (EPS)
0.159
Dividend (TTM)
0
Dividend Yield
0.00%
Shares Outstanding
1.65M
Currency Unit
USD
ADVB Price Performance
7 day
30 day
90 day
180 day
Year to date
1 Year
ADVB Money Flow Distribution
ADVB Daily Short Sale Volume
ADVB Short Interest History
ADVB Stock Snapshot
As of 2026-07-22, the Advanced Biomed Inc. (ADVB) stock price today is 16.1532. Based on this price, the company has a market capitalization of $14.70M, with a P/E ratio of 44.47.
On 2026-07-22, ADVB traded between 8.08 and 17.50. Today’s stock price is 99.92% above the daily low and 7.70% below the daily high, placing ADVB near the upper end of its most recent trading range.
Trading volume currently stands at 18.89M, compared with an average daily volume of 3.83M. This suggests that trading activity is significantly above its usual level than usual.
Over the past year, Advanced Biomed Inc. shares have traded between 3.61 and 17.50. At today’s price, ADVB is 347.46% above its 52-week low and 7.70% below its 52-week high.
ADVB Related News
About ADVB
Company Name
Advanced Biomed Inc.
Sector
Health Technology
Industry
Biotechnology
Exchanges
Nasdaq
Number of Employees
31
Lot Size
100
Official Website
Currency Unit
USD
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Related Stocks
ADVB FAQ
© 2026 CoinGlass, all rights reserved
